Show Summary Details
Page of

Treatment-Resistant Social Anxiety Disorder 

Treatment-Resistant Social Anxiety Disorder
Treatment-Resistant Social Anxiety Disorder

Eric Bui

and Mark H. Pollack

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 November 2018

Social anxiety disorder (SAD) is characterized by a persistent fear of being embarrassed or humiliated in social or performance situations leading to marked impairment and distress. It is estimated that around 12% of the US population suffers from this condition. Although advances in the treatment of SAD have provided effective treatment options, it has been reported that only one half to two thirds of patients respond to a first line of treatment. This present chapter reviews the current knowledge on SAD and evidence-based treatments, including cognitive-behavioral therapy, serotonin reuptake inhibitors, and other medications. Treatment options for managing treatment-resistant SAD, including optimization of first-line pharmacotherapy, switching, and augmentation, will also be discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.